Sleep and Maximal Fat Oxidation (Sleep&Fat)

University of Alcala

Status: Completed

Conditions: Sleep Deprivation

Treatments: Behavioral: Sleep deprivation; Behavioral: Sleep place

Study type: Interventional

Funder types: Other

Identifiers

NCT07015008

CEID/2023/6/119_2

Details and patient eligibility

About

Introduction: Despite the awareness of the importance of sleep in our lives, especially for athletes, the consequences of poor rest on sports performance are not well understood. Furthermore, the interaction between complete and partial sleep deprivation over one night and sleeping the usual hours for each person remains unclear.

Objectives: The aim of this study is to evaluate the effects of sleep deprivation on maximal fat oxidation (MFO) in male and female participants.

Enrollment: 32 patients

Sex: All

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Inclusion Criteria:

  • Age between 18 and 35 years.
  • Body Mass Index (BMI) < 25 kg/m².
  • Resistance-trained individuals (more than 2 years of structured training).
  • Healthy men and women without neurological, cardiometabolic, immunological, or physical conditions that prevent them from exercising.
  • Participants must be able to perform the tests described in the following section.

Exclusion criteria

• History of neuromuscular diseases, heart disease, or conditions that may affect liver or muscle metabolism.
• Use of drugs, stimulants, or sports supplements that could interfere with the dietary supplement used in the study.
• Sedentary habits (less than 150 minutes/week of moderate exercise).
• Having undergone prolonged periods of physical inactivity in the 6 months prior to the study.
• Engaging in strenuous exercise within 48 hours prior to the tests.
• Failure to replicate the same food intake on both experimental days.
• Consumption of caffeine or any other stimulant the day before the tests.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind

---

32 participants in 4 patient groups, including a placebo group

8h Sleep (at home)

Placebo Comparator group

Description:

Arm Description: Participants sleep 8h at home

Treatment:

Behavioral: Sleep place

Behavioral: Sleep deprivation

8h Sleep (Laboratory)

Experimental group

Description:

Participants sleep 8h in the lab

Treatment:

Behavioral: Sleep place

Behavioral: Sleep deprivation

4h Sleep (Laboratory)

Experimental group

Description:

Participants sleep 4h in the laboratory

Treatment:

Behavioral: Sleep deprivation

0h Sleep (Laboratory)

Experimental group

Description:

Participants sleep 0h in the laboratory

Treatment:

Behavioral: Sleep deprivation